STING1 and breast carcinoma: Taken together, these results suggest that AKT1 is a crucial regulator of STING signaling in endocrine‐resistant breast cancer cells and that knockdown of AKT1 or targeting AKT1 by MK2206 could release the activity of STING signaling.